ORBIMED ADVISORS LLC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1055951 New York, NY

Position in CTMX

as of Dec 31, 2025 · filed Feb 17, 2026 Compact

Position Value

$15,019,269

-$11,972,916 QoQ

Shares Held

3,525,650

-58.3% QoQ

Ownership

1.62%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $2,871,604,021 across 72 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	EWTX	Edgewise Therapeutics, Inc.	15,518,492	$488,832,498
2	ELVN	Enliven Therapeutics, Inc.	7,959,538	$312,013,889
3	SION	Sionna Therapeutics, Inc.	3,530,702	$141,545,843
4	MBX	MBX Biosciences, Inc.	3,637,887	$108,590,926
5	CRVS	Corvus Pharmaceuticals, Inc.	7,165,006	$104,824,037
6	ARGX	Argenx SE	136,900	$99,971,225
7	CMPX	Compass Therapeutics, Inc.	15,219,994	$80,513,768
8	GPCR	Structure Therapeutics Inc.	1,475,403	$71,114,424

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$15,019,269	3,525,650	0.0%	Shares	Sole	2026-02-17
2025-12-31	$15,019,269	3,525,650	-58.3%	Shares	Sole	2026-02-17
2025-09-30	$26,992,185	8,461,500	0.0%	Shares	Sole	2025-11-14
2025-06-30	$19,207,605	8,461,500	0.0%	Shares	Sole	2025-08-14
2025-06-30	$19,207,605	8,461,500	+138.7%	Shares	Sole	2025-08-14
2024-03-31	$7,727,180	3,544,578	+66.8%	Shares	Defined	2024-05-15
2022-06-30	$3,888,704	2,124,975	0.0%	Shares	Defined	2022-08-15
2022-03-31	$5,673,683	2,124,975	-33.9%	Shares	Defined	2022-05-16
2021-12-31	$13,918,823	3,214,509	+76.4%	Shares	Defined	2022-02-14
2021-09-30	$9,273,308	1,821,868	+20.4%	Shares	Defined	2021-11-15
2021-06-30	$9,578,353	1,513,168	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.